The DEAD box protein Ddx42p modulates the function of ASPP2, a stimulator of apoptosis

被引:21
|
作者
Uhlmann-Schiffler, H. [1 ]
Kiermayer, S. [1 ]
Stahl, H. [1 ]
机构
[1] Univ Saarland, Dept Med Biochem & Mol Biol, D-6642 Homburg, Germany
关键词
apoptosis; ASPP2; Ddx42p; p53; ubiquitination; MESSENGER-RNA; KAPPA-B; TUMOR-SUPPRESSOR; P53; HELICASE; 53BP2; EXPRESSION; P68; PROLIFERATION; INHIBITION;
D O I
10.1038/onc.2009.75
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Ddx42p is a recently characterized mammalian DEAD box protein with unknown cellular function. We found that in human cells Ddx42p physically interacts with ASPP2, a major apoptosis inducer known to enhance p53 transactivation of proapoptotic genes. The proteins interact via a domain within the carboxy-terminal part of Ddx42p and a mid-amino-terminal sequence as well as the ankyrin-SH3 region of ASPP2. Overexpression of Ddx42p interferes with apoptosis induction by ASPP2, whereas Ddx42p knockdown reduces the survival rate of cultured human cells. In addition, ASPP2 is found in cytoplasm and nucleus at low Ddx42p level, and predominantly in cytoplasm at high concentration of Ddx42p, respectively. Our results show that Ddx42p is capable of modulating ASPP2 function. Oncogene (2009) 28, 2065-2073; doi:10.1038/onc.2009.75; published online 20 April 2009
引用
收藏
页码:2065 / 2073
页数:9
相关论文
共 50 条
  • [1] The DEAD box protein Ddx42p modulates the function of ASPP2, a stimulator of apoptosis
    H Uhlmann-Schiffler
    S Kiermayer
    H Stahl
    Oncogene, 2009, 28 : 2065 - 2073
  • [2] Ddx42p - a human DEAD box protein with RNA chaperone activities
    Uhlmann-Schiffler, H
    Jalal, C
    Stahl, H
    NUCLEIC ACIDS RESEARCH, 2006, 34 (01) : 10 - 22
  • [3] Apoptosis Stimulating Protein of p53 2 (ASPP2) expression in acute leukemia modulates response to therapy
    Kampa-Schittenhelm, K.
    Kanz, L.
    Schittenhelm, M.
    ONKOLOGIE, 2011, 34 : 87 - 87
  • [4] Insights into the role of ASPP2 (Apoptosis stimulating protein of p53-2) in lymphomagenesis
    Kampa-Schittenhelm, K. M.
    Mueller, S.
    Bonin, M.
    Kanz, L.
    Schittenhelm, M. M.
    Lopez, C. D.
    ONKOLOGIE, 2010, 33 : 256 - 256
  • [5] Apoptosis stimulating protein of p53 (ASPP) 1 and ASPP2 m-RNA expression in oral cancer
    Patel, Kinjal D.
    Barasiya, Yesha, V
    Patel, Jayendra B.
    Patel, Prabhudas S.
    ARCHIVES OF ORAL BIOLOGY, 2020, 119
  • [6] Insights Into the Role of ASPP2 (Apoptosis Stimulating Protein of p53-2) in Lymphomagenesis.
    Kampa, Kerstin M.
    Mueller, Sandra
    Bonin, Michael
    Schittenhelm, Marcus M.
    Lopez, Charles D.
    BLOOD, 2009, 114 (22) : 779 - 779
  • [7] Control of ASPP2/53BP2L protein levels by proteasomal degradation modulates p53 apoptotic function
    Zhu, ZY
    Ramos, J
    Kampa, K
    Adimoolam, S
    Sirisawad, M
    Yu, ZY
    Chen, DX
    Naumovski, L
    Lopez, CD
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (41) : 34473 - 34480
  • [8] Proteins that interact with Apoptotic Stimulator Protein of p53, ASPP2, in the yeast two-hybrid system
    Bray, BA
    Grigoreff, Y
    Forbus, JD
    Beavers, SY
    Ruiz, MI
    Butler, KA
    Warthen, LM
    Rohde, LH
    FASEB JOURNAL, 2004, 18 (08): : C105 - C106
  • [9] ASPP2 k, a Dominant-Negative Splicing Variant of the Apoptosis-Stimulating Protein of p53-2 (ASPP2), Modulates Treatment Response Towards BCL-Signaling Inhibitors in Acute Myeloid Leukemia
    Schittenhelm, Marcus M.
    Tsintari, Vasileia
    Froehlich, Rebecca
    Kampa-Schittenhelm, Kerstin Maria
    BLOOD, 2021, 138
  • [10] Factor inhibiting HIF-1 (FIH-1) modulates protein interactions of apoptosis-stimulating p53 binding protein 2 (ASPP2)
    Janke, Kirsten
    Brockmeier, Ulf
    Kuhlmann, Katja
    Eisenacher, Martin
    Nolde, Jan
    Meyer, Helmut E.
    Mairbaeurl, Heimo
    Metzen, Eric
    JOURNAL OF CELL SCIENCE, 2013, 126 (12) : 2629 - 2640